ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Outcome"

  • 2022 American Transplant Congress

    Very Small Pediatric Donors May Help Address the Sex Disparity in Access to Kidney Transplantation

    J. Yu, J. Sageshima, M. Nuño, N. Mineyev, N. Goussous, R. Perez

    UC Davis Medical Center, Sacramento, CA

    *Purpose: Women with end-stage renal disease have lower access to deceased donor kidney transplantation than men. Expanding the donor pool to include kidneys from very…
  • 2022 American Transplant Congress

    Prospective Evaluation of Donor-Derived Cell-Free DNA (dd-cfDNA) in Monitoring Response to Anti-Rejection Treatment in Kidney Transplant Recipients with Indication Biopsy

    L. Benning1, A. Fink2, F. Kälble1, C. Speer1, C. Nusshag1, M. Zeier1, C. Süsal3, C. Morath1, T. Tran2

    1Department of Nephrology, University Hospital Heidelberg, Heidelberg, Germany, 2Transplantation Immunology, Institute of Immunology, University Hospital Heidelberg, Heidelberg, Germany, 3Transplant Immunology Research Center of Excellence, Koç University Hospital, Istanbul, Turkey

    *Purpose: Donor-derived cell-free DNA (dd-cfDNA) is a marker of allograft injury in kidney transplant recipients (KTR). Little is known about the possible use of dd-cfDNA…
  • 2022 American Transplant Congress

    Evaluation of a Change in Pharmacy Discharge Medication Education for Kidney Transplant Recipients

    M. Borsh1, M. Leick1, A. Donovan2, C. McAdam-Marx2, M. Keck1

    1Pharmacy, Nebraska Medicine, Omaha, NE, 2College of Pharmacy, University of Nebraska Medical Center, Omaha, NE

    *Purpose: To evaluate if modification of pharmacy discharge education for kidney transplant recipients contributed to a decreased length of hospital stay (LOS) post-transplant.*Methods: This was…
  • 2022 American Transplant Congress

    A Novel Mismatch That Modulates the Innate Alloresponse Risk Stratifies Renal Transplant Patients

    H. Dai, K. Abou Daya, M. Oberbarnscheidt, R. Mehta, C. Macedo, D. Metes, Q. Xu, A. Zeevi, P. Randhawa, F. Lakkis, A. Cherukuri

    Thomas E. Starzl Transplantation Institute, UPMC, Pittsburgh, PA

    *Purpose: Donor polymorphism in the gene encoding signal regulatory protein alpha (SIRPα) is a key modulator of the recipient’s innate alloresponse. Here, we investigated the…
  • 2022 American Transplant Congress

    Longitudinal Mortality Risks and Renal Functional Outcomes in Living Kidney Donors

    K. Hotta1, T. Osawa1, I. Yokota2, T. Inao2, T. Tanabe1, N. Iwahara1, N. Shinohara1

    1Urology, Hokkaido University Hospital, Sapporo, Japan, 2Biostatistics, Hokkaido University Graduate School of Medicine, Sapporo, Japan

    *Purpose: Previous studies have suggested that living kidney donors do not have a higher risk of death or end-stage kidney disease (ESKD) than the general…
  • 2022 American Transplant Congress

    Living Related Kidney Donation for Alport Syndrome Spectrum: Long-Term Outcomes

    Y. Caliskan1, A. B. Dirim2, S. Safak2, B. Yelken3, A. Velioglu4, A. Yildiz5, O. A. Oto2, N. Guller2, H. Yazici2, A. Ersoy5, A. Turkmen3, K. L. Lentine1

    1Saint Louis University, Saint Louis, MO, 2Istanbul University, Istanbul, Turkey, 3Koc University Hospital, Istanbul, Turkey, 4Marmara University, Istanbul, Turkey, 5Uludag University, Bursa, Turkey

    *Purpose: Data to guide the evaluation of living related donor (LRD) candidates for kidney transplant recipients with Alport syndrome (AS) spectrum are limited. We examined…
  • 2022 American Transplant Congress

    Transplant Coordinator Time Saved (TCTS) Through a Hybrid On Call Team for Deceased Donor Kidney and Pancreas Transplant Organ Offers

    K. Ko, C. Gregory, J. Le, A. Lutrick, U. Reddy

    Division of Kidney and Pancreas Transplantation, UC Irvine, Orange, CA

    *Purpose: The purpose of this analysis was to estimate transplant coordinator time saved (TCTS) through the implementation of a hybrid on call team. Historically, transplant…
  • 2022 American Transplant Congress

    Evaluation of Diabetes-Free Life Expectancy Among Living Kidney Donors and Non-Donors with Obesity: A Longitudinal Cohort Study

    C. Killian1, R. Reed1, M. McLeod1, P. MacLennan1, V. Kumar1, S. Brooks1, A. Maynor1, L. Stanford1, G. Baker1, C. Schinstock2, J. Silkensen3, G. Roll4, D. Segev5, B. Orandi1, C. Lewis1, J. Locke1

    1University of Alabama at Birmingham, Birmingham, AL, 2Mayo Clinic, Rochester, MN, 3Hennepin County Medical Center, Minneapolis, MN, 4UCSF Medical Center, San Francisco, CA, 5Johns Hopkins University, Baltimore, MD

    *Purpose: The growing end stage kidney disease burden paired with substantial rates of obesity in the United States (US) has prompted increased approval of obese…
  • 2022 American Transplant Congress

    The New Heart Allocation Policy Has Increased Listing by Exception

    J. R. Golbus1, Y. Ahn2, B. K. Nallamothu1, M. N. Walsh3, D. Zaun2, A. Israni2, M. Colvin1

    1University of Michigan, Ann Arbor, MI, 2Hennepin Healthcare Research Institute, Minneapolis, MN, 3Ascension St. Vincent Heart Center, Carmel, IN

    *Purpose: The new heart allocation policy (October 2018) expanded the number of listing statuses and established a national review board for exception requests in an…
  • 2022 American Transplant Congress

    Metabolic Outcomes After Pancreas Transplant Alone from Donation After Circulatory Death Donor – The UK Registry Analysis

    J. Gopal, A. McLean, A. Muthusamy

    Imperial College Renal and Transplant Center, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom

    *Purpose: Extrapolating data from early DCD (donation after circulatory death) kidney transplantation, pancreas transplants from DCD grafts were feared to have worse metabolic outcomes. Hence,…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 155
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences